When a mid-level FDA regulator quietly rewrote drug approval guidelines three weeks before joining a pharmaceutical company, it exposed how the revolving door between government and industry actually works—not through grand corruption, but through perfectly legal career incentives that reshape policy in real time. We trace how one bureaucrat's job hunt changed what medicines reach your pharmacy shelf.